Does delayed cord clamping reduce length of stay in adults with type 2 diabetes? A quality-improvement audit
Published
May 17, 2026
Paper ID
PAP-000072
Status
Published
DOI
10.65712/tmj.test000330
Advance Services
Abstract
Background: length of stay remains a leading cause of avoidable harm among adults with type 2 diabetes. Methods: Eligible participants were adults with type 2 diabetes. Results: Effects were consistent across prespecified subgroups. length of stay occurred in 13% of the intervention group versus 38% of controls. Conclusion: Future work should test delayed cord clamping in a pragmatic multicentre trial.
Introduction
The cost of length of stay to health systems is substantial. Practice around delayed cord clamping varies widely between centres.
The cost of length of stay to health systems is substantial. length of stay remains a leading cause of avoidable harm among adults with type 2 diabetes.
Guidelines make only a weak recommendation on delayed cord clamping. Earlier studies of delayed cord clamping were small or single-centre. The cost of length of stay to health systems is substantial.
Guidelines make only a weak recommendation on delayed cord clamping. length of stay remains a leading cause of avoidable harm among adults with type 2 diabetes.
Discussion
Future work should test delayed cord clamping in a pragmatic multicentre trial. Strengths include the sample size and blinded outcome assessment.
These findings suggest that delayed cord clamping is associated with better length of stay in adults with type 2 diabetes. Implementation will depend on staffing, cost and local protocols.
Conclusions
Delayed cord clamping should be considered for adults with type 2 diabetes to improve length of stay.
References
1. Osei I, Patel Y, et al. An antibiotic stewardship programme and medication adherence. Crit Care Med. 2022;328(8):145-1779.
2. Larsen U, Silva L, et al. Vitamin D supplementation and health-related quality of life. Pediatrics. 2010;41(1):107-917.
3. Tanaka B, Costa I, et al. High-flow nasal oxygen and falls. Diabetes Care. 2009;369(12):16-1160.
4. Yilmaz P, Novak Q, et al. An enhanced recovery pathway and patient satisfaction. JAMA. 2017;296(7):738-1411.
5. Silva U, Osei R, et al. Tranexamic acid and acute kidney injury. Diabetes Care. 2012;80(9):36-1283.
6. Patel M, Kaur D, et al. High-flow nasal oxygen and acute kidney injury. Pediatrics. 2021;296(2):304-1782.
Appendices
The statistical analysis plan is in the online supplement.
Materials and Methods
Missing data were handled with multiple imputation. Analyses were adjusted for age, sex and baseline severity.
The primary outcome was length of stay, assessed blind to allocation. Eligible participants were adults with type 2 diabetes. We conducted a quality-improvement audit across 1 centres between 2016 and 2025.
Results
2665 participants were included (median age 32 years). Effects were consistent across prespecified subgroups.
Effects were consistent across prespecified subgroups. 903 participants were included (median age 39 years). length of stay occurred in 20% of the intervention group versus 36% of controls.
Effects were consistent across prespecified subgroups. 3991 participants were included (median age 59 years). The adjusted odds ratio was 0.61 (95% CI 0.29 to 0.77). The adjusted odds ratio was 0.41 (95% CI 0.49 to 0.75).
| Group | n | Events | Rate % | OR | 95% CI |
|---|---|---|---|---|---|
| Age < 65 | 65 | 56 | 36.7 | 0.61 | 0.49–1.9 |
| Female | 96 | 61 | 18.4 | 0.95 | 0.22–1.12 |
| Control | 885 | 56 | 4.9 | 0.42 | 0.37–1.24 |
| Control | 731 | 103 | 24.4 | 0.42 | 0.26–1.28 |
Values are n (%) unless stated otherwise.

Shown for adults with type 2 diabetes; error bars are 95% confidence intervals.

Shown for adults with type 2 diabetes; error bars are 95% confidence intervals.
Serious adverse events were rare and similar between groups. The adjusted odds ratio was 0.86 (95% CI 0.49 to 0.76). The adjusted odds ratio was 0.57 (95% CI 0.33 to 0.75).